Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Current Assets (2016 - 2025)

Historic Current Assets for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $1.1 billion.

  • Integra Lifesciences Holdings' Current Assets rose 400.72% to $1.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 billion, marking a year-over-year increase of 400.72%. This contributed to the annual value of $1.1 billion for FY2024, which is 223.48% up from last year.
  • As of Q3 2025, Integra Lifesciences Holdings' Current Assets stood at $1.1 billion, which was up 400.72% from $1.1 billion recorded in Q2 2025.
  • In the past 5 years, Integra Lifesciences Holdings' Current Assets ranged from a high of $1.4 billion in Q1 2024 and a low of $1.0 billion during Q3 2023
  • For the 5-year period, Integra Lifesciences Holdings' Current Assets averaged around $1.1 billion, with its median value being $1.1 billion (2021).
  • In the last 5 years, Integra Lifesciences Holdings' Current Assets surged by 3751.09% in 2024 and then plummeted by 2178.53% in 2025.
  • Integra Lifesciences Holdings' Current Assets (Quarter) stood at $1.2 billion in 2021, then rose by 0.67% to $1.2 billion in 2022, then fell by 8.91% to $1.1 billion in 2023, then increased by 2.23% to $1.1 billion in 2024, then increased by 5.72% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.